| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
Lysozyme C, encoded by the LYZ gene, serves as a critical component of the innate immune system, functioning as an antimicrobial enzyme that hydrolyzes bacterial cell wall peptidoglycans. Beyond its well-established role in host defense, lysozyme has emerged as a valuable marker in studies of monocyte and macrophage biology, inflammatory responses, and certain hematological malignancies where its expression patterns provide diagnostic and prognostic insights.
This recombinant monoclonal antibody, clone 10H11, offers the reproducibility and consistency that demanding research applications require. Because the antibody sequence is defined and produced recombinantly in rabbit host cells, researchers can expect uniform performance across experiments and studies, eliminating the lot-to-lot variability that can complicate longitudinal projects or multi-site collaborations.
Validation studies demonstrate reliable detection of lysozyme in Western blot applications across multiple human cell lines, including HL-60 promyelocytic leukemia cells and HepG2 hepatocellular carcinoma cells, with effective detection at dilutions ranging from 1:500 to 1:2000. The observed band at approximately 15 kDa aligns well with the predicted molecular weight of 17 kDa, with minor differences likely attributable to post-translational processing or gel migration characteristics. The antibody has also been validated for ELISA applications, providing flexibility for researchers working across different experimental platforms.
Whether investigating innate immunity mechanisms, characterizing myeloid cell populations, or exploring lysozyme's emerging roles in inflammatory disease models, this affinity-purified antibody delivers the specificity and batch consistency needed for confident, reproducible results in your research program.
Email: support@cusabio.com
Distributors Worldwide